Comparison Bioline Rx (BLRX) with Competitors
Bioline Rx (BLRX) industry is Biotechnology.
Operating Margin
BLRX-630.00%
Industry-2055.25%
Upside+1425.25%
Debt-to-Equity
BLRX54.40%
Industry28.27%
Upside+92.44%
Free Cash Flow Yield
BLRX-58.62%
Industry-1.75%
Upside-56.87%
P/E
BLRX-1.40
Industry-20.52
Upside+1911.56%
Forward P/E
BLRX93.46
Industry16.35
Upside+471.64%
P/S
BLRX9.56
Industry10.01
Upside-4.53%
P/B
BLRX0.76
Industry5.15
Upside-85.25%